
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $46M | -- | -- | -$0.05 | -- |
08/08/2025 | Q2 | $43.7M | -- | -- | -$0.06 | -- |
05/13/2025 | Q1 | $26.4M | $29.1M | -$0.09 | -$0.10 | $0.01 |
03/27/2025 | Q4 | $3.8M | $5.7M | -$0.09 | -$0.09 | -$0.00 |
11/07/2024 | Q3 | $5.4M | $2M | -$0.09 | -$0.10 | $0.01 |
08/08/2024 | Q2 | $4.4M | $5.3M | -$0.09 | -$0.08 | -$0.01 |
05/02/2024 | Q1 | $4.6M | $4M | -$0.08 | -$0.06 | -$0.02 |
03/07/2024 | Q4 | $4.3M | $4.4M | -$0.08 | -$0.05 | -$0.03 |
11/13/2023 | Q3 | -- | -- | -$0.07 | -$0.05 | -$0.02 |
08/10/2023 | Q2 | -- | -- | -$0.06 | -$0.05 | -$0.01 |
05/10/2023 | Q1 | -- | -- | -$0.07 | -$0.06 | -$0.01 |
03/09/2023 | Q4 | -- | -- | -$0.11 | -$0.06 | -$0.05 |
11/08/2022 | Q3 | -- | -- | -$0.19 | -$0.07 | -$0.12 |
08/08/2022 | Q2 | -- | -- | -$0.06 | -$0.08 | $0.02 |
05/09/2022 | Q1 | -- | -- | -$0.08 | -$0.07 | -$0.01 |
02/24/2022 | Q4 | -- | -- | -$0.08 | -$0.07 | -$0.01 |
11/10/2021 | Q3 | -- | -- | -$0.07 | -$0.07 | -$0.00 |
08/12/2021 | Q2 | -- | -- | -$0.09 | -$0.05 | -$0.04 |
05/13/2021 | Q1 | -- | -- | -$0.05 | -$0.04 | -$0.02 |
02/23/2021 | Q4 | -- | -- | -$0.15 | -$0.04 | -$0.11 |
11/10/2020 | Q3 | -- | -- | -$0.09 | -$0.09 | -$0.00 |
08/10/2020 | Q2 | -- | -- | -$0.40 | -$0.25 | -$0.15 |
03/31/2020 | Q1 | -- | -- | -$0.64 | -$0.45 | -$0.20 |
03/27/2020 | Q4 | -- | -- | -$0.50 | -$0.53 | $0.03 |
11/12/2019 | Q3 | -- | -- | -$0.66 | -$0.55 | -$0.11 |
08/14/2019 | Q2 | -- | -- | -$0.61 | -$0.37 | -$0.24 |
05/08/2019 | Q1 | -- | -- | -$0.63 | -$0.47 | -$0.16 |
03/27/2019 | Q4 | -- | -- | -$0.87 | -$0.66 | -$0.21 |
11/06/2018 | Q3 | -- | -- | -$0.85 | -$0.60 | -$0.25 |
08/08/2018 | Q2 | -- | -- | -- | -- | -- |
05/10/2018 | Q1 | -- | -- | -$5.20 | -$4.80 | -$0.40 |
03/28/2018 | Q4 | -- | -- | -$5.20 | -$5.20 | -- |
11/06/2017 | Q3 | -- | -- | -$7.20 | -$8.20 | $1.00 |
08/03/2017 | Q2 | -- | -- | -$8.80 | -$10.80 | $2.00 |
03/31/2017 | Q1 | -- | -- | -- | -- | -- |
03/29/2017 | Q4 | -- | -- | -$22.80 | -$19.20 | -$3.60 |
11/14/2016 | Q3 | -- | -- | -- | -- | -- |
08/09/2016 | Q2 | -- | -- | -- | -- | -- |
05/12/2016 | Q1 | -- | -- | -- | -- | -- |
03/29/2016 | Q4 | -- | -- | -- | -- | -- |
11/05/2015 | Q3 | -- | -- | -- | -- | -- |
Gevo reported $29.1M worth of top line sales in its most recent quarter.
Gevo announced earnings per share of -$0.09 which represents a beat of analyst forecast a -$0.10 per share.
Gevo reported $7.7M that represents $0.03 per share over the last quarter.
Gevo's earnings are forecast to decrease from -$0.34 per share to -$0.38 per share next year representing a decrease of -17.65%.
Gevo's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.